+1 213-510-3499 sales@vparesearch.com
+1 213-510-3499 sales@vparesearch.com
Home/ Healthcare
Industry Coverage

Healthcare Market Research & Reports

Healthcare is being revolutionized by telemedicine, AI‑assisted diagnostics, precision therapeutics, and value‑based care models. VPA Research provides exhaustive analyses of pharmaceutical pipelines, medical device innovation, digital health platforms, and hospital service trends. We track regulatory pathways (FDA, EMA), reimbursement shifts, and patient engagement strategies impacting adoption rates. With granular forecasts by therapy area, device type, and delivery model, our insights support life sciences companies, providers, payers, and investors in navigating a complex, patient‑centric healthcare landscape.

Latest Reports in Healthcare

Explore syndicated research, market outlooks, and sector-specific analysis curated for strategy and growth teams.

2457 reports available

Cell and Gene Therapy CDMO Market Size, Share and Growth Outlook, 2026: Analysis By Therapy (Cell Therapy , Gene Therapy , Gene-Modified Cell Therapy ), By Service Type (Process Development and Analytical Testing, Clinical-Stage Development and Manufacturing, Commercial-Scale GMP Manufacturing, Fill-Finish and Packaging Services), By Indication (Oncology, Rare Diseases and Genetic Disorders, Neurological and Central Nervous System Disorders, Infectious and Cardiovascular Diseases), By Client (Biopharmaceutical and Pharmaceutical Corporations, Biotech Startups and Universities) Companies, and Country Forecast, 2021 to 2034

Global Cell and Gene Therapy CDMO Market size is forecast to increase from $6.23 Billion in 2026 to $31.8 Billion in 2034 at a CAGR of 22.6% between 2026 and 2034.

Published: June 2026
Report Code: VPA10006267
Pages: 224 Pages

Cell and Gene Therapy Bioanalytical Testing Services Market Size, Share and Growth Outlook, 2026: Analysis By Test Type (Bioavailability & Bioequivalence Studies, Pharmacokinetics, Pharmacodynamics, Biomarker Testing, Cell-based Assays, Others), By Product Type (Gene Therapy, Gene-modified Cell Therapy, Cell Therapy), By Stage of Development (Non-clinical, Clinical), By Indication (Oncology, Autoimmune Diseases, Rare Diseases, Others) Companies, and Country Forecast, 2021 to 2034

Global Cell and Gene Therapy Bioanalytical Testing Services Market size is forecast to increase from $576.76 Million in 2026 to $1005.9 Million in 2034 at a CAGR of 7.2% between 2026 and 2034.

Published: June 2026
Report Code: VPA10006266
Pages: 221 Pages

Cell Analysis Market Size, Share and Growth Outlook, 2026: Analysis By Product & Service (Reagents and Consumables , Instruments , Software and Bioinformatics Tools, Services ), By Technique (Flow Cytometry, Polymerase Chain Reaction , Microscopy and Automated Cell Imaging, High-Content Screening , Mass Spectrometry, Cell Microarrays), By Core Application (Cellular Identification and Sorting, Cell Viability, Proliferation, and Health Screening, Single-Cell Analysis, Cell Signaling Pathways and Structure Studies, Toxicology and Drug Screening, Oncology and Clinical Diagnostics), By End-User (Pharmaceutical and Biotechnology Enterprises, Academic and Dedicated Research Institutes, Hospitals and Clinical Testing Laboratories, Contract Research Organizations) Companies, and Country Forecast, 2021 to 2034

Global Cell Analysis Market size is forecast to increase from $27.34 Billion in 2026 to $64.38 Billion in 2034 at a CAGR of 11.3% between 2026 and 2034.

Published: June 2026
Report Code: VPA10006265
Pages: 212 Pages

Cell Analysis Instruments Market Size, Share and Growth Outlook, 2026: Analysis By Product Type (Flow Cytometers, High-Content Screening , Microscopes and Imaging Systems, Spectrophotometers, Polymerase Chain Reaction , Cell Microarrays and Automated Counters), By Application (Cell Counting and Quality Control, Cell Viability and Proliferation, Cell Identification and Characterization, Target Identification and Validation, Single-Cell Analysis, Cell Signaling Pathways and Interaction Studies), By Technology Modality (Label-Based Cell Analysis, Label-Free Cell Analysis), By End-User (Pharmaceutical and Biotechnology Companies, Academic and Government Research Institutes, Contract Research Organizations , Hospitals and Diagnostic Laboratories) Companies, and Country Forecast, 2021 to 2034

Global Cell Analysis Instruments Market size is forecast to increase from $25.13 Billion in 2026 to $44.82 Billion in 2034 at a CAGR of 7.5% between 2026 and 2034.

Published: June 2026
Report Code: VPA10006264
Pages: 213 Pages

Celiac Disease Drugs Market Size, Share and Growth Outlook, 2026: Analysis By Product Type (Vitamin & Mineral Supplements, Immunomodulators & Biologics, Enzyme-based Therapies, Barrier Modulators), By Route of Administration (Oral, Parenteral), By End-User (Hospitals, Specialty Clinics, Homecare Settings) Companies, and Country Forecast, 2021 to 2034

Global Celiac Disease Drugs Market size is forecast to increase from $893.87 Million in 2026 to $1958.3 Million in 2034 at a CAGR of 10.3% between 2026 and 2034.

Published: June 2026
Report Code: VPA10006263
Pages: 214 Pages

Ceftiofur Market Size, Share and Growth Outlook, 2026: Analysis By Product Formulation (Ceftiofur Sodium , Ceftiofur Hydrochloride , Ceftiofur Crystalline Free Acid ), By Target Animal Type (Cattle , Swine, Horses, Poultry & Others), By Application (Bovine Respiratory Disease , Swine Respiratory Disease , Acute Bovine Interdigital Necrobacillosis , Acute Metritis, Urinary Tract Infections), By Distribution Channel (Veterinary Hospitals & Clinics, Institutional Procurement & Government Tenders, Retail Pharmacies & Veterinary Feed Stores) Companies, and Country Forecast, 2021 to 2034

Global Ceftiofur Market size is forecast to increase from $1.93 Billion in 2026 to $3.42 Billion in 2034 at a CAGR of 7.4% between 2026 and 2034.

Published: June 2026
Report Code: VPA10006262
Pages: 218 Pages

CDKL5 Deficiency Disorder (CDD) Market Size, Share and Growth Outlook, 2026: Analysis By Therapy Type (Antiseizure Medications , Targeted, Gene Therapy & Enzyme Replacement , Supportive & Rehabilitative Therapies ), By Symptom Management (Epilepsy & Seizure Management, Motor & Movement Disorder Management, Gastrointestinal & Nutritional Support, Sleep Disorder Management), By Patient Demographic (Pediatric Patients, Adolescent Patients, Adult Patients), By End-User (Hospitals & Specialized Neurological Centers, Academic & Research Institutes, Rehabilitation & Long-term Care Centers) Companies, and Country Forecast, 2021 to 2034

Global CDKL5 Deficiency Disorder (CDD) Market size is forecast to increase from $141.53 Million in 2026 to $212.8 Million in 2034 at a CAGR of 5.23% between 2026 and 2034.

Published: June 2026
Report Code: VPA10006261
Pages: 221 Pages

CBD Pet Market Size, Share and Growth Outlook, 2026: Analysis By Product Form (Oils & Tinctures, Edibles & Treats , Capsules & Softgels, Topicals ), By Animal Type (Dogs, Cats, Horses, Other Small Pets ), By Indication (Anxiety & Stress Management, Pain & Inflammation Relief , Epilepsy & Seizure Control, General Wellness & Skin Care), By Distribution Channel (Online, Pet Specialty Stores, Veterinary Clinics & Hospital Pharmacies, Retail Pharmacies & Supermarkets) Companies, and Country Forecast, 2021 to 2034

Global CBD Pet Market size is forecast to increase from $589.87 Million in 2026 to $5178.77 Million in 2034 at a CAGR of 31.2% between 2026 and 2034.

Published: June 2026
Report Code: VPA10006260
Pages: 214 Pages

CBD Nutraceuticals Market Size, Share and Growth Outlook, 2026: Analysis By Product Type (CBD Tinctures and Drops, Capsules and Softgels, CBD Gummies and Edibles, Liquid Beverages and Mixes, CBD Protein Powders and Workout Supplements), By Core Function (Chronic Pain and Inflammatory Management, Cognitive Health, Stress, and Anxiety Relief, Sleep Cycle Support, Skin Health and Anti-Aging Beauty Supplements, Immune System and General Wellness Support), By Consumer Type Focus (Adult Consumers, Geriatric Consumers, Athletes and Fitness Enthusiasts), By Sales and Distribution Channel (Offline Retail Channels , Online Sales Channels) Companies, and Country Forecast, 2021 to 2034

Global CBD Nutraceuticals Market size is forecast to increase from $11.88 Billion in 2026 to $32.49 Billion in 2034 at a CAGR of 13.4% between 2026 and 2034.

Published: June 2026
Report Code: VPA10006259
Pages: 216 Pages

CBD Consumer Health Market Size, Share and Growth Outlook, 2026: Analysis By Product Category (Medical OTC Products, Nutraceuticals and Dietary Supplements), By Indication (Pain Management and Analgesics, Mental Health, Stress, and Anxiety Relief, Sleep Supports and Insomnia Aids, Dermatology and Skincare, Weight Management and Wellbeing), By Source Material (Hemp-Derived CBD, Marijuana-Derived CBD), By Extract Type (Full-Spectrum CBD, Broad-Spectrum CBD, CBD Isolate), By Distribution Channel (Hospital and Retail Pharmacies, Online Stores , Specialty Health and Wellness Stores, Hypermarkets and Supermarkets) Companies, and Country Forecast, 2021 to 2034

Global CBD Consumer Health Market size is forecast to increase from $24.98 Billion in 2026 to $81.33 Billion in 2034 at a CAGR of 15.9% between 2026 and 2034.

Published: June 2026
Report Code: VPA10006258
Pages: 218 Pages